FDA Approval Activities for this Drug
Nicardipine Hydrochloride Capsules, 20 mg & 20 mg. Genpharm, ANDA 74-928 NICARDIPINE HYDROCHLORIDE Capsule, Extended Release; 30MG CARDENE SR ROCHE PALO
020005 NICARDIPINE HYDROCHLORIDE Capsule, Extended Release; 45MG CARDENE SR ROCHE PALO
020005 NICARDIPINE HYDROCHLORIDE Capsule, Extended Release; 60MG CARDENE SR ROCHE PALO
074928 NICARDIPINE HYDROCHLORIDE Capsule; 20MG NICARDIPINE HCL Genpharm 074928 NICARDIPINE HYDROCHLORIDE Capsule; 30MG NICARDIPINE HCL Genpharm 074439 NICARDIPINE HYDROCHLORIDE Capsule; 20MG NICARDIPINE HCL Ivax 074439 NICARDIPINE HYDROCHLORIDE Capsule; 30MG NICARDIPINE HCL Ivax 074642 NICARDIPINE HYDROCHLORIDE Capsule; 20MG NICARDIPINE HCL Mylan
074642 NICARDIPINE HYDROCHLORIDE Capsule; 30MG NICARDIPINE HCL Mylan
019488 NICARDIPINE HYDROCHLORIDE Capsule; 20MG CARDENE ROCHE PALO
019488 NICARDIPINE HYDROCHLORIDE Capsule; 30MG CARDENE ROCHE PALO
074540 NICARDIPINE HYDROCHLORIDE Capsule; 20MG NICARDIPINE HCL Teva
074540 NICARDIPINE HYDROCHLORIDE Capsule; 30MG NICARDIPINE HCL Teva
074670 NICARDIPINE HYDROCHLORIDE Capsule; 20MG NICARDIPINE HCL Watson 074670 NICARDIPINE HYDROCHLORIDE Capsule; 30MG NICARDIPINE HCL Watson 019734 NICARDIPINE HYDROCHLORIDE Injection 2.5MG/ML CARDENE ROCHE PALO | Nicardipine Hydrochloride Capsules, Barr Labs, Facility Addition | Cardene I.V. (nicardipine hydrochloride), PDL BioPharma, Labeling Revision | Nicardipine Hydrochloride Injection, Teva Parenteral Medicines, Approval | Cardene (nicardipine hydrochloride) Injection, EKR Therapeutics, Inc., Formulation Revision